Mutations in the DNM2 gene are associated with three distinct autosomal dominant neuromuscular disorders: Charcot–Marie–Tooth neuropathy (CMT1B, MIM# 606482), spastic paraplegia (Sambuughin et al., 2015) and centronuclear myopathy (ADCNM, MIM# 160150), the predominant centronuclear myopathy (CNM) form in adult patients (Bitoun et al., 2005; Zuchner et al., 2005). Here, DNM2 is linked to autosomal dominant centronuclear myopathy.